¶¶زُ¶جتسئµ

header-logo
GettyImages-758308167-hero
Biostatistics
Rodney Sparapani, PhD

Rodney Sparapani, PhD

Associate Professor, Biostatistics

Locations

  • Biostatistics

Contact Information

Education

PhD, Biostatistics, ¶¶زُ¶جتسئµ, Milwaukee, WI, 2011
MS, Mathematics, Marquette University, Milwaukee, WI, 1991
BS, Mathematics, Michigan Technological University, Houghton, MI, 1989

Biography

Dr. Rodney Sparapani is an associate professor, Institute for Health & Humanity, Biostatistics at the ¶¶زُ¶جتسئµ. He joined the division in December 2013.

Research Experience

  • Administrative Claims, Healthcare
  • Clinical Trials Data Monitoring Committees
  • Electronic Health Records
  • Observational Study
  • Randomized Controlled Trial

Methodologies and Techniques

  • Bayesian Analysis
  • Biostatistics
  • Causality
  • Machine Learning
  • Medical Informatics
  • Statistics, Nonparametric
  • Survival Analysis

¶¶زُ¶جتسئµ Program / Core Facilities

  • Research Computing Center Faculty Advisory Committee

Educational Expertise

  • Education, Graduate
  • Teaching Biostatistics

Research Interests

Dr. Sparapani's research applies Bayesian methodology to modern biostatistical problems such as survival analysis, health services research, causal inference, comparative effectiveness research and big data/omics. Recently, he has focused on Bayesian machine learning, Bayesian nonparametrics and the surrounding challenges of efficient computation with large data sets. His collaborative research has involved the analysis of cancer treatments, cardiovascular disease and a wide variety of other conditions such as diabetes, osteoporosis, hepatitis, hip fracture, sinus surgery and spine surgery.

Publications

  • (Feuling MB, Hilbrands J, Hettich K, Kopesky J, Martin N, McCarthy R, Osinski K, Pipkorn R, Smith A, Sparapani RA, Teng BQ, Goday PS.) J Acad Nutr Diet. 2025 May 28 PMID: 40446925 05/31/2025

  • (Mehta RS, Sparapani R, Wang T, Spellman S, Lee SJ, Petersdorf EW.) Am J Hematol. 2025 May;100(5):937-940 PMID: 40056061 SCOPUS ID: 2-s2.0-105000009387 03/09/2025

  • (Fernando DG, Sparapani R, Mogal H.) J Surg Oncol. 2025 Mar;131(4):725-733 PMID: 39552156 SCOPUS ID: 2-s2.0-85209680992 11/18/2024

  • (Neuner JM, Stolley M, Kamaraju S, Tiegs J, Sparapani R, Makris V, Flynn KE.) Breast Cancer Res Treat. 2025 Feb;209(3):541-552 PMID: 39592520 SCOPUS ID: 2-s2.0-85210370572 11/27/2024

  • (Bagherimohamadipour M, Hammad M, Visotcky A, Sparapani R, Kulinski J.) Front Cardiovasc Med. 2025;12:1546462 PMID: 40357442 PMCID: PMC12066452 SCOPUS ID: 2-s2.0-105004768525 05/13/2025

  • (Kay C, Sherman K, Sparapani R.) J Opioid Manag. 2025;21(2):131-140 PMID: 40326725 SCOPUS ID: 2-s2.0-105003715067 05/06/2025

  • (Spellman SR, Sparapani R, Maiers M, Shaw BE, Laud P, Bupp C, He M, Devine SM, Logan BR.) Blood Adv. 2024 Dec 10;8(23):6082-6087 PMID: 39368807 PMCID: PMC11652765 SCOPUS ID: 2-s2.0-85212173730 10/06/2024

  • (Rubin MJ, Wakinekona NA, Reilly MA, Canales B, Sparapani R, Dyer M, Kibbe MR, Mansukhani NA.) J Vasc Surg. 2024 Dec;80(6):1871-1882 PMID: 38901638 PMCID: PMC11585452 SCOPUS ID: 2-s2.0-85199130838 06/21/2024

  • (Peterson KJ, Drezdzon MK, Sparapani R, Calata JF, Ridolfi TJ, Ludwig KA, Peterson CY.) J Surg Res. 2024 Oct;302:916-924 PMID: 39265279 SCOPUS ID: 2-s2.0-85203426182 09/13/2024

  • (Al Tannir AH, Pokrzywa CJ, Sparapani R, Maring M, Saltzman C, Tignanelli CJ, Duthie E, Haines K, Nattinger A, Carver TW, de Moya MA, Morris RS.) J Surg Res. 2024 Sep;301:269-279 PMID: 38986192 SCOPUS ID: 2-s2.0-85198034792 07/11/2024

  • (Bagherimohamadipour M, Hammad M, Visotcky A, Sparapani R, Kulinski J.) medRxiv. 2024 Jul 27 PMID: 39108506 PMCID: PMC11302710 08/07/2024

  • (Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A.) Blood Cancer J. 2024 May 26;14(1):61 PMID: 38796476 PMCID: PMC11127981 SCOPUS ID: 2-s2.0-85194268737 05/26/2024

Publications of from the

© 2025 ¶¶زُ¶جتسئµ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ¶¶زُ¶جتسئµ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

¶¶زُ¶جتسئµ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ¶¶زُ¶جتسئµ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.